Skip to content

Internet Buzz (October 25, 2012) On Sarepta Therapeutics, Orphan Drug Eteplirsen, And Duchenne Muscular Dystrophy

October 26, 2012

        Internet buzz on Sarepta Therapeutics’ orphan drug Eteplirsen for treatment of Duchenne Muscular Dystrophy (DMD) : 

1)  TheStreet.com October 25, 2012 article titled, “Sarepta Therapeutics Inc (SRPT): Today’s Featured Health Care Laggard”  

2)  SeekingAlpha.com October 25, 2012 article titled,”Sarepta Part II: Commercial Potential of Eteplirsen In The Next Hot Market For Orphan Drug”  

3)  SeekingAlpha.com October 25, 2012 article titled,”This $1 Biotech Stock Offers Limited Downside With Huge Reward Potential”  

4)  YouTube October 25, 2012 posting of Video,”Q&A with Sarepta President & CEO, Chris Garabedian”    

Copyright  © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: